Please check your internet connection and try again.
# IV Dexamethasone
## Overview
Dexamethasone is a potent synthetic glucocorticoid with strong anti-inflammatory and immunosuppressive effects. It is available in various formulations including intravenous.
## Primary Indications
* Allergic states
* Dermatologic diseases
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic disorders
* Neoplastic diseases (palliation)
* Nervous system disorders (e.g., cerebral edema)
* Ophthalmic diseases
* Renal diseases
* Respiratory diseases
* Rheumatic disorders
* Organ transplant rejection
## Adult Dosing
Dosing is highly variable depending on the indication and severity of the condition.
* **Anti-inflammatory/Immunosuppressive:** 0.5 mg to 9 mg daily, often divided into 1 to 4 doses.
* **Cerebral Edema:** 10 mg IV initially, followed by 4 mg IV every 6 hours. Dosing depends on clinical response and may be tapered.
* **Adrenal Insufficiency:** 0.5 mg to 9 mg daily.
* **Dose for specific indications will depend on local protocols and physician judgment.**
## Pediatric Dosing
Dosing is typically based on severity and patient weight. Specific dosing will depend on local protocols.
* **General Dosing:** 0.15 mg/kg/day divided every 6 to 12 hours, or 0.03 mg/kg/dose every 8 to 12 hours.
* **Maximum dose:** Not to exceed adult doses.
## Dose Adjustments
* **Hepatic Impairment:** Dose reduction may be necessary.
* **Renal Impairment:** No specific adjustment typically needed, but monitor for fluid retention.
## Contraindications
* Systemic fungal infections
* Known hypersensitivity to dexamethasone or other corticosteroids
* Intra-articular injection in infected joints or areas of cellulitis
## Adverse Effects
* **Endocrine:** Hyperglycemia, adrenal suppression, Cushingoid state, menstrual irregularities.
* **Gastrointestinal:** Peptic ulceration, increased appetite, nausea, vomiting.
* **Musculoskeletal:** Osteoporosis, muscle weakness, growth suppression in children.
* **Neurologic:** Insomnia, mood changes, psychosis, seizures.
* **Ophthalmic:** Glaucoma, cataracts.
* **Cardiovascular:** Fluid retention, hypertension.
* **Dermatologic:** Impaired wound healing, acne, rash.
* **Immunologic:** Increased susceptibility to infections.
## Key Drug Interactions
* **CYP3A4 Inducers (e.g., rifampin, phenytoin, carbamazepine):** May decrease dexamethasone levels.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase dexamethasone levels.
* **Diuretics:** Increased risk of hypokalemia.
* **Anticoagulants (e.g., warfarin):** May alter anticoagulant effect.
* **Live Vaccines:** Increased risk of disseminated infection.
## Monitoring
* Blood glucose
* Electrolytes (especially potassium)
* Signs of infection
* Growth in pediatric patients
* Bone density with long-term use
* Ophthalmic pressure and visual acuity with long-term use
## Clinical Pearls
* Dexamethasone has minimal mineralocorticoid activity, making it less likely to cause sodium and water retention compared to other corticosteroids.
* Stress doses (higher doses) may be required during periods of illness, surgery, or trauma in patients on chronic steroid therapy.
* Tapering of dose is crucial when discontinuing long-term therapy to prevent adrenal insufficiency.
* May mask signs of infection.
***
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to ensure the most accurate and up-to-date information regarding drug therapy. Verify current prescribing information before making any clinical decisions.
